Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia

Second‐line treatment trends and long‐term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years

(2020) Stéphane Ducassou et al.   BRITISH JOURNAL OF HAEMATOLOGY

Fatigue in children and adolescents with immune thrombocytopenia

(2020) Rachael F. Grace et al.   BRITISH JOURNAL OF HAEMATOLOGY

Severe immune thrombocytopenic purpura in critical COVID-19

(2020) Valérie Lévesque et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

(2020) Corrado Lodigiani et al.   THROMBOSIS RESEARCH

Rethinking high-risk groups in COVID-19

(2020) Anastasia Vishnevetsky et al.   Multiple Sclerosis and Related Disorders

Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials

(2020) Michael D. Tarantino et al.   PEDIATRIC BLOOD & CANCER

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia

(2019) Michael D. Tarantino et al.   HAEMATOLOGICA

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies

(2019) David J. Kuter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes

(2019) Rachael F. Grace et al.   AMERICAN JOURNAL OF HEMATOLOGY

Thrombopoietin receptor agonists: Ten Years Later

(2019) Waleed Ghanima et al.   HAEMATOLOGICA

Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?

(2019) Alexandra Schifferli et al.   Frontiers in Immunology

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

(2019) John Grainger et al.   BLOOD

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children

(2018) Rachael F. Grace et al.   AMERICAN JOURNAL OF HEMATOLOGY

Intravenous immunoglobulin versus observation in childhood immune thrombocytopenia: a randomized controlled trial

(2018) Katja M.J. Heitink-Pollé et al.   BLOOD

Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI

(2018) Axel Matzdorff et al.   Oncology Research and Treatment

Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura

(2017) Elena V. Suntsova et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)

(2017) Anne Zufferey et al.   Journal of Clinical Medicine

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

(2016) Michael D Tarantino et al.   LANCET

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Romiplostim on Health-Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents

(2016) Susan D. Mathias et al.   PEDIATRIC BLOOD & CANCER

Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study

(2016) Cindy Neunert et al.   PEDIATRIC BLOOD & CANCER

Hospitalizations in pediatric patients with immune thrombocytopenia in the United States

(2016) Michael D. Tarantino et al.   PLATELETS

Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review

(2015) C. Neunert et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Health-related quality of life in children with newly diagnosed immune thrombocytopenia

(2014) K. M. J. Heitink-Polle et al.   HAEMATOLOGICA

Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children

(2014) Kavitha Ramaswamy et al.   JOURNAL OF PEDIATRICS

Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)

(2014) James B. Bussel et al.   PEDIATRIC BLOOD & CANCER

Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic

(2014) T. Brezina et al.   VALUE IN HEALTH

Cost-Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia In Portugal

(2014) M. Augusto et al.   VALUE IN HEALTH

To Treat or Not To Treat—From Guidelines to Individualized Patient Management

(2013) Axel Matzdorff et al.   SEMINARS IN HEMATOLOGY

Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists

(2013) Bahareh Ghadaki et al.   TRANSFUSION

Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland

(2013) Dawn Lee et al.   Applied Health Economics and Health Policy

Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort

(2012) Steen Rosthøj et al.   ACTA PAEDIATRICA

A Randomized, Open-Label, 5-Period, Balanced Crossover Study to Evaluate the Relative Bioavailability of Eltrombopag Powder for Oral Suspension (PfOS) and Tablet Formulations and the Effect of a High-Calcium Meal on Eltrombopag Pharmacokinetics When Administered With or 2 Hours Before or After PfOS

(2012) Mary Beth Wire et al.   CLINICAL THERAPEUTICS

Use of Romiplostim for Primary Immune Thrombocytopenia in Children

(2012) Vicente Escudero Vilaplana et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

The burden of immune thrombocytopenia in adults: Evaluation of the thrombopoietin receptor agonist romiplostim

(2012) Robert Deuson et al.   JOURNAL OF MEDICAL ECONOMICS

Romiplostim in children with chronic refractory ITP: randomized placebo controlled study

(2011) Mohsen Saleh Elalfy et al.   ANNALS OF HEMATOLOGY

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

(2011) J. B. Bussel et al.   BLOOD

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

(2011) T. Kuhne et al.   HAEMATOLOGICA

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

(2010) W. Bao et al.   BLOOD

Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database

(2010) Mellissa Yong et al.   BRITISH JOURNAL OF HAEMATOLOGY

The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports

(2009) Deirdra R. Terrell et al.   AMERICAN JOURNAL OF HEMATOLOGY

Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies

(2009) Daphne D. Williams et al.   CLINICAL THERAPEUTICS

Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives

(2009) Jacqueline A. Guidry et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura

(2009) Cindy E. Neunert et al.   PEDIATRIC BLOOD & CANCER

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD